Cell Death Inducing p53 Target Protein 1 (CDIP1)

[Edit]

C16orf5; CDIP; LITAFL; Cell Death-Inducing Protein; LITAF-Like Protein; Lipopolysaccharide-Induced Tumor Necrosis Factor-Alpha-Like Protein; Transmembrane Protein I1

Cell Death Inducing p53 Target Protein 1 (CDIP1)
Bhalla et al. (1999) identified C16ORF5 near a region of chromosome 16 involved in a de novo translocation ascertained in a patient with epilepsy and mental retardation, and cloned the cDNA. The deduced 261-amino acid protein contains 40% proline residues in 104 N-terminal amino acids and 14 cysteines in the C-terminal portion. It has a single N-glycosylation site, 3 N-myristoylation sites, and 2 phosphorylation sites. Northern blot analysis detected high expression of the 2.4-kb transcript in brain, weaker expression in heart, skeletal muscle, kidney, pancreas, and liver, and little to no expression in placenta and lung. Bhalla et al. (1999) predicted C16ORF5 to localize to the nucleus.Bhalla et al. (1999) determined that the C16ORF5 gene contains at least 4 exons and spans about 10 kb.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Cell Death Inducing p53 Target Protein 1 (CDIP1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Cell Death Inducing p53 Target Protein 1 (CDIP1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cell Death Inducing p53 Target Protein 1 (CDIP1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cell Death Inducing p53 Target Protein 1 (CDIP1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cell Death Inducing p53 Target Protein 1 (CDIP1) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Cell Death Inducing p53 Target Protein 1 (CDIP1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Cell Death Inducing p53 Target Protein 1 (CDIP1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cell Death Inducing p53 Target Protein 1 (CDIP1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cell Death Inducing p53 Target Protein 1 (CDIP1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cell Death Inducing p53 Target Protein 1 (CDIP1) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Cell Death Inducing p53 Target Protein 1 (CDIP1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Cell Death Inducing p53 Target Protein 1 (CDIP1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cell Death Inducing p53 Target Protein 1 (CDIP1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cell Death Inducing p53 Target Protein 1 (CDIP1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cell Death Inducing p53 Target Protein 1 (CDIP1) ELISA Kit Customized Service Offer
  1. "C16orf5, a novel proline-rich gene at 16p13.3, is highly expressed in the brain."J. Hum. Genet. 44:383-387(1999) [PubMed] [Europe PMC] [Abstract]
  2. "CDIP, a novel pro-apoptotic gene, regulates TNFalpha-mediated apoptosis in a p53-dependent manner."EMBO J. 26:3410-3422(2007) [PubMed] [Europe PMC] [Abstract]
  3. "Towards a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs." Genome Res. 11:422-435(2001) [PubMed] [Europe PMC] [Abstract]
  4. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  5. "The sequence and analysis of duplication-rich human chromosome 16." Nature 432:988-994(2004) [PubMed] [Europe PMC] [Abstract]
  6. "The full-ORF clone resource of the German cDNA consortium."BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract]
  7. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]